Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

445 ARTÍCULOS , VIENDO DEL 346 AL 360

Effects of Hippeastrum reticulatum on memory, spatial learning and object recognition in a scopolamine-induced animal model of Alzheimer's disease

Hoang THX, Ho DV, Van Phan K, Le QV, Raal A, Nguyen HT.

Pharm Biol. 2020 Dec;58(1):1098-1104. doi: 10.1080/13880209.2020.1841810.

Can We Treat Neuroinflammation in Alzheimer's Disease?

Sánchez-Sarasúa S, Fernández-Pérez I, Espinosa-Fernández V, Sánchez-Pérez AM, Ledesma JC.

Int J Mol Sci. 2020 Nov 19;21(22):8751. doi: 10.3390/ijms21228751.

Reactions to Multiple Ascending Doses of the Microtubule Stabilizer TPI-287 in Patients With Alzheimer Disease, Progressive Supranuclear Palsy, and Corticobasal Syndrome: A Randomized Clinical Trial

Tsai RM, Miller Z, Koestler M, Rojas JC, Ljubenkov PA, Rosen HJ, Rabinovici GD, Fagan AM, Cobigo Y, Brown JA, Jung JI, Hare E, Geldmacher DS, Natelson-Love M, McKinley EC, Luong PN, Chuu EL, Powers R, Mumford P, Wolf A, Wang P, Shamloo M, Miller BL, Roberson ED, Boxer AL.

JAMA Neurol. 2020 Feb 1;77(2):215-224. doi: 10.1001/jamaneurol.2019.3812.

Blood-based Biomarkers of Alzheimer's Disease: The Long and Winding Road

Manzine PR, Vatanabe IP, Peron R, Grigoli MM, Pedroso RV, Nascimento CMC, Cominetti MR.

Curr Pharm Des. 2020;26(12):1300-1315. doi: 10.2174/1381612826666200114105515.

Anti-Amyloid Aggregating Gold Nanoparticles: Can they Really be Translated from Bench to Bedside for Alzheimer's Disease Treatment?

Shaikh S, Nazam N, Danish Rizvi SM, Hussain T, Farhana A, Choi I.

Curr Protein Pept Sci. 2020;21(12):1184-1192. doi: 10.2174/1389203721666200226101930.

Targetting Exosomes as a New Biomarker and Therapeutic Approach for Alzheimer's Disease

Yin Q, Ji X, Lv R, Pei JJ, Du Y, Shen C, Hou X.

Clin Interv Aging. 2020 Feb 13;15:195-205. doi: 10.2147/CIA.S240400. eCollection 2020.

Clinical Experience in Treatment of Alzheimer's Disease with Jiannao Yizhi Formula () and Routine Western Medicine

Wang HC, Liu NY, Zhang S, Yang Y, Wang ZY, Wei Y, Liu JG, Pei H, Li H.

Chin J Integr Med. 2020 Mar;26(3):212-218. doi: 10.1007/s11655-019-2718-2. Epub 2020 Mar 16.

Potential Therapeutic Approaches for Cerebral Amyloid Angiopathy and Alzheimer's Disease

Tanaka M, Saito S, Inoue T, Satoh-Asahara N, Ihara M.

Int J Mol Sci. 2020 Mar 14;21(6):1992. doi: 10.3390/ijms21061992.

Alzheimer's disease beyond amyloid: Can the repetitive failures of amyloid-targeted therapeutics inform future approaches to dementia drug discovery?

Mullane K, Williams M.

Biochem Pharmacol. 2020 Jul;177:113945. doi: 10.1016/j.bcp.2020.113945. Epub 2020 Apr 2.

Early Diagnosis and Targeted Treatment Strategy for Improved Therapeutic Outcomes in Alzheimer's Disease

Guest FL, Rahmoune H, Guest PC.

Adv Exp Med Biol. 2020;1260:175-191. doi: 10.1007/978-3-030-42667-5_8.

Fluorinated Molecules and Nanotechnology: Future 'Avengers' against the Alzheimer's Disease?

Dabur M, Loureiro JA, Pereira MC.

Int J Mol Sci. 2020 Apr 23;21(8):2989. doi: 10.3390/ijms21082989.

Insulin and leptin as potential cognitive enhancers in metabolic disorders and Alzheimer's disease

Mejido DCP, Peny JA, Vieira MNN, Ferreira ST, De Felice FG.

Neuropharmacology. 2020 Jul;171:108115. doi: 10.1016/j.neuropharm.2020.108115. Epub 2020 Apr 25.

Current and Future of Alzheimer's Therapy with the Best Approach

Singh H, Chawla V, Bala R, Dureja H.

CNS Neurol Disord Drug Targets. 2020;19(9):691-697. doi: 10.2174/1871527319666200430000538.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias